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It is known that secreted proteins from the anterior lateral endoderm, FGF8 and BMP2, are involved in
mesodermal cardiac differentiation, which determines the ﬁrst cardiac ﬁeld, deﬁned by the expression of
the earliest speciﬁc cardiac markers Nkx-2.5 and Gata4. However, the molecular mechanisms responsible
for early cardiac development still remain unclear. At present, microRNAs represent a novel layer of
complexity in the regulatory networks controlling gene expression during cardiovascular development.
This paper aims to study the role of miR130 during early cardiac speciﬁcation.
Our model is focused on developing chick at gastrula stages. In order to identify those regulatory
factors which are involved in cardiac speciﬁcation, we conducted gain- and loss-of-function experiments
in precardiac cells by administration of Fgf8, Bmp2 and miR130, through in vitro electroporation tech-
nique and soaked beads application. Embryos were subjected to in situ hybridization, im-
munohistochemistry and qPCR procedures. Our results reveal that Fgf8 suppresses, while Bmp2 induces,
the expression of Nkx-2.5 and Gata4. They also show that Fgf8 suppresses Bmp2, and vice versa. Ad-
ditionally, we observed that Bmp2 regulates miR-130 -a putative microRNA that targets Erk1/2 (Mapk1)
3′UTR, recognizing its expression in precardiac cells which overlap with Erk1/2 pattern. Finally, we
evidence that miR-130 is capable to inhibit Erk1/2 and Fgf8, resulting in an increase of Bmp2, Nkx-2.5 and
Gata4.
Our data present miR-130 as a necessary linkage in the control of Fgf8 signaling, mediated by Bmp2,
establishing a negative feed-back loop responsible to achieve early cardiac speciﬁcation.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
During early chick gastrulation, groups of cells from the epi-
blast, speciﬁed as precardiac cells, invaginate through the primi-
tive streak just caudal to its rostral end and Hensen's node (Garcia-
Martinez and Schoenwolf, 1993; Garcia-Martinez et al., 1997; Lo-
pez-Sanchez et al., 2001, 2009). These cells migrate in an anterior–
lateral direction between the ectoderm and endoderm to form a
crescent of mesoderm in the most anterior part of the embryo,
known as precardiac mesoderm area (Schultheiss et al., 1995;
Redkar et al., 2001). This region is also identiﬁed as “ﬁrst (primary)
cardiac ﬁeld” (FCF; Harvey, 2002), in order to differentiate it from
the secondary cardiac ﬁeld, a new group of cells that also con-
tribute to heart development after cardiac tube formation,nez).involving some others morphogenetic mechanisms (Hurle et al.,
1977; Hurle and Ojeda, 1979; Mjaatvedt et al., 2001; Waldo et al.,
2001; Kelly et al., 2014).
Precardiac anterior lateral mesoderm is deﬁned by the ex-
pression of transcription factors Nkx-2.5 (Schultheiss et al., 1995)
and Gata4 (Laverriere et al., 1994), which are detected in a crescent
shape pattern at stage 5-6 HH (Hamburger and Hamilton, 1951).
Cardiac fate speciﬁcation requires a close association between the
precardiac mesoderm and the adjacent endoderm. Previous ex-
perimental evidence suggests that bone morphogenetic protein –
BMP2, emanating from the adjacent endoderm, induces Nkx-2.5
expression in the precardiac mesoderm (Schultheiss et al., 1995,
1997). In particular, misexpression experiments in chick embryos,
by applying exogenous BMP2 -medial to the FCF, result in induc-
tion of Nkx-2.5 expression (Schultheiss et al., 1997, Andrée et al.,
1998). In addition, ectopic exogenous administration of BMP2 is
also capable of inducing Gata4 (Schultheiss et al., 1997, Andrée
C. Lopez-Sanchez et al. / Developmental Biology 406 (2015) 63–7364et al., 1998) and Fgf8 (Alsan and Schultheiss, 2002). It has also been
shown that several members of the ﬁbroblast growth factor family
– FGF – induce cardiogenic markers in non-precardiac mesoderm,
since FGF8 administration – lateral to the FCF – results in induc-
tion of Nkx-2.5 – but not of Bmp2- expression (Alsan and Schul-
theiss, 2002). Moreover, we have previously shown that FGF4 is
able to induce the expression of Nkx-2.5 in non-precardiogenic
tissue, at the level of the germinal cell crescent (Lopez-Sanchez
et al., 2002). Interestingly, in some other non-precardiogenic tis-
sues, such as explanted caudal lateral mesoderm, a combination of
BMP2 and FGF4, but neither factor alone, is able to induce Nkx-2.5
expression (Lough et al., 1996; Barron et al., 2000). All these data
suggest that initial cardiac speciﬁcation is regulated by complex
relationships between Bmp and Fgf signaling pathways, coopera-
tion which has been proposed at later stages of cardiac develop-
ment during myocardial and epicardial formation (Kruithof et al.,
2006).
However, the intrinsic mechanisms involved in the crosstalk
between Fgf and Bmp signaling, responsible for the induction and
transcription factor regulation, still remain unclear. It has been
proposed that mitogen-activated protein kinases (MAPKs) are
highly conserved family proteins that play an integral role in signal
transduction and regulation during cardiac development (see Rose
et al., 2010). Additionally, ERK1/2 (extracellular signal-regulated
kinase), one of MAPK subfamilies, has been involved in Fgf sig-
naling pathway, playing a crucial role in the interaction Fgf–Bmp
signals during cardiac differentiation at later developing stages
(van Wijk et al., 2009; Tirosh-Finkel et al., 2010; Hutson et al.,
2010). Interestingly, by means of bioinformatic analysis through
TargetScan prediction of microRNA targets (Lewis et al., 2003), we
identiﬁed miR-130 as a putative microRNA that targets ERK1/2 3
´UTR. Guided by this prediction, we focused on the above men-
tioned molecular factors for early cardiac speciﬁcation. MicroRNAs
represent a novel layer of complexity in the regulatory networks
controlling gene expression, cell speciﬁcation and differentiation
(Choi et al., 2013; Hosoda, 2013). MicroRNAs constitute a subclass
of non-coding RNAs, with approximately 22-24 nucleotides in
length, which by base-pair complementarity can bind to target
mRNA and either trigger transcript degradation or protein trans-
lational blockage (Bartel, 2004; Cao and Chen, 2012). Over the last
few years, the role of microRNAs in cardiac development and
disease has progressively emerged (Lozano-Velasco et al., 2011;
Chen and Wang, 2012; Espinoza-Lewis and Wang, 2012; Porello,
2013; De Rosa et al., 2014). Moreover, microRNA microarray ex-
pression analyses have identiﬁed, during cardiac development, a
large set of microRNAs with increasing expression during ven-
tricular maturation, including miR-130 (Chinchilla et al., 2011).
Although little is known about miR-130 function to date, it has
been referred in several adult and embryonic cardiovascular pro-
cesses (Svensson et al., 1999; Chen and Gorski, 2008; Jakob et al.,
2012; Osbourne et al., 2014). Gene ontology analyses revealed that
targeting Bmp signaling was selectively represented among those
up-regulated microRNAs (Chinchilla et al., 2011).
In order to gain an insight into the role of these molecular
factors during early cardiac development, in this work we have
carried out a series of experiments based on gain- and loss-of-
function of Fgf8 and Bmp2 to dissect their effects on miR-130
expression and function during cardiac speciﬁcation. Our results
provide evidence about the presence of a negative feed-back loop
between Fgf8 and Bmp2, mediated by miR-130, constituting a
crucial element involved on the establishment of the precise pat-
terning of the early developing heart.
2. Materials and methods
Experimental protocols with animals were performed inagreement with the Spanish law in application of the EU Guide-
lines for animal research, and conformed to the Guide for the Care
and Use of Laboratory Animals, published by the US National In-
stitutes of Health (NIH Publication no. 85-23). Approval by the
University of Extremadura bioethics board was obtained prior to
the initiation of the study.
For further details on the methodology see Appendix A.
2.1. Early chick whole embryo culture
Fertilized eggs (Granja Santa Isabel, Córdoba, Spain) were in-
cubated at 38 °C in forced-draft humidiﬁed incubators. Embryos
were staged (PS stages: Lopez-Sanchez et al., 2005; HH stages:
Hamburger and Hamilton, 1951) and subjected to early chick (EC)
embryo culture (Chapman et al., 2001).
2.2. Embryo electroporation of precardiac primitive streak cells
Cultured embryos were injected and electroporated in pre-
cardiac primitive streak cells. For gain-of-function experiments,
three different groups of embryos were electroporated, with Fgf8
expressing construct (pCS2-Fgf8), Bmp2 expressing construct
(pIRES-Bmp2-EGFP) and pre-miR-130, respectively. Likewise, for
loss-of-function experiments, two different groups of embryos
were electroporated, with Fgf8 siRNA expressing construct (pSi-
lencer-Fgf8) and anti-miR-130, respectively. For control embryos,
EGFP expressing construct (pCAGGs-EGFP), or CFDA, was electro-
porated. Embryos were additionally incubated for 14–16 h.
2.3. Bead implantation
For gain-of-function experiments, beads were soaked either in
FGF8 or in BMP2 solutions. In the same way, for loss-of-function
experiments, beads were soaked either in noggin (an antagonist of
BMP signals) or in SU5402 (FGF receptor inhibitor) solutions.
Soaked beads were implanted at the desired site, and the embryos
were additionally incubated for 6–8 h.
After the experimental procedure, all embryos were ﬁxed
overnight in 4% PFA, dehydrated in methanol and stored at
20 °C. Alternatively, embryos were selected and processed for
whole mount in situ hybridization, while others were processed
for immunohistochemistry.
2.4. Whole-mount in situ hybridization (ISH) and sectioning
Embryos were hydrated by incubation in graded methanol/PBT
(PBS, 0.1% Tween 20) steps to a pure sterile PBT solution. Embryos
were processed for ISH following standard procedure (Chapman
et al., 2002) using antisense-Fgf8, -Bmp2, -Nkx-2.5, and -Gata4 la-
beled probes, respectively. Double ISH (Chapman et al., 2002) was
also performed using antisense-Fgf8 and -Bmp2 probes. A group of
embryos was processed (Darnell et al., 2006) for ISH with LNA-
labeled microRNA probes (Exiqon) against miR-130.
For histology, embryos were dehydrated with an ethanol series,
cleared in isopropanol and processed for paraplast embedding,
obtaining 15 μm transverse serial sections.
2.5. Immunohistochemistry (IMH)
Whole mount IMH was performed (Lopez-Sanchez et al., 2004)
by using policlonal rabbit phospho-P44/42 MAPK/ERK1/2 antibody
(Cell Signaling), followed by anti-rabbit IgG-HRP antibody
(Chemicon).
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Pre-miR-130, anti-miR-130 and control (CDFA) electroporated
embryos were collected and the primitive endocardial tubes were
carefully dissected. Total RNA isolation was performed using Trizol
reagent (Roche) according to the manufacturer’s guidelines. For
qRT-PCR analyses, DNAse treatment was performed during 1 h at
37 °C prior to cDNA synthesis using SuperScript RT III (Invitrogen)
detection system. Real time PCR experiments were performed
with 1 μL of cDNA, SsoFast EvaGreen mix and corresponding pri-
mer sets. All qPCRs were performed using a CFX384TM thermo-
cycler (Bio-Rad) following the manufacturer's recommendations.
The relative level of expression of each gene was calculated (Livak
and Schmittgen, 2001) by using Gapdh and Gusb as internal con-
trol. Each PCR reaction was carried out in triplicate and repeated in
at least three distinct pooled biological samples to obtain re-
presentative means.
A number of 12–15 embryos – successfully developed – were
selected for every particular procedure.Fgf8 Bmp2Fgf8 Bmp2
HH8 HH 9
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Fig. 1. Whole-mount ISH for Fgf8 and Bmp2 during early chick development in
control embryos. Note Fgf8 expression (arrowhead) medially to Bmp2 (arrow) at
primitive endocardial tube level. (A) After sagital section, the same embryo was
processed for ISH. The right half (left image) was processed for Fgf8, and the left
half (right image) was processed for Bmp2. Note the different topological expres-
sion pattern. The white line indicates the transverse section level, to show Bmp2
expression in the precardiac mesoderm and the underlying endoderm (arrows),
and Fgf8 expression just in the underlying endoderm (arrowhead). (B)–(D): Double
ISH for Fgf8 (in red) and Bmp2 (in blue), simultaneously. FCF: ﬁrst cardiac ﬁeld. PET:
primitive endocardial tube.3. Results
Previous studies have shown a relevant role for FGF8 and BMP2
proteins, secreted from the endoderm, as inductive signals of
cardiogenesis on the adjacent precardiac mesodermal cells
(Schultheiss et al., 1997; Alsan and Schultheiss, 2002). However,
the precise spatio-temporal relationship between these two in-
ductive signals during heart development remains rather elusive.
It was previously reported (Lopez-Sanchez and Garcia-Martinez,
2011) that Fgf8 and Bmp2 are ﬁrstly expressed at the level of the
primitive streak, and subsequently on the endoderm adjacent to
the precardiac mesoderm (see Supplementary Fig. 1). Interestingly,
using double ISH at later stages, we observed that Fgf8 displays a
more medial expression as compared to Bmp2 expression pattern
(Fig. 1). Such a partial overlap is consistently observed as well at
later developmental stages, just after the primitive endocardial
tubes are formed.
3.1. Fgf8 modulates cardiac speciﬁc markers in a topologically de-
pendent manner
Fgf8 gain-of-function experiments, by electroporation of the
prospective cardiogenic primitive streak cells at PS4 stage as
previously described (Lopez-Sanchez et al., 2005), demonstrate
that expression of cardiac speciﬁc markers such as Nkx-2.5 and
Gata4 is signiﬁcantly suppressed at the level of primitive en-
docardial tubes (Fig. 2A). Importantly, Bmp2 expression is also
diminished by Fgf8 overexpression. In order to further support
these ﬁndings, FGF8-soaked beads were applied speciﬁcally inside
FCF at PS11 stage. As expected, FGF8 suppresses Bmp2, Nkx-2.5 and
Gata4 expression (Fig. 2B) at the level of the ipsilateral endocardial
tube. Remarkably, application of FGF8 -soaked beads- laterally to
FCF leads to Nkx-2.5 induction (Fig. 2C), in line with previous re-
ports (Alsan and Schultheiss, 2002).
In order to further explore the role of Fgf8 in early cardiogen-
esis, Fgf8 loss-of-function complementary approach was carried
out, through electroporation with Fgf8 siRNA expressing construct,
within the prospective cardiogenic cells at primitive streak stages
(PS4). Our results demonstrate (Fig. 3A) that Fgf8 expression is
inhibited, and concomitantly, Bmp2, Nkx-2.5 and Gata4 expression
is increased.
FGF signaling is mediated via tyrosine kinase receptors (FGFRs)
acting through a number of diverse transduction pathways
(Böttcher and Niehrs, 2005), such as the highly conserved Ras-
Erk1/2/MAPK (mitogen-activated protein kinase) cascade. It hasbeen previously reported (Echevarria et al., 2005) that Fgf8 signals
are mediated by Erk1/2 (MAPK). In this regards, we therefore ex-
plored the Erk1/2 (MAPK) response after our Fgf8 loss-of-function
experiments, showing a markedly decreased expression of Erk1/2
protein (Fig. 3A).
Remarkably, application of SU5402 –soaked beads- speciﬁcally
inside FCF (a chemical blocker of FGF signal by speciﬁcally binding
to FGFR1; Eblaghie et al., 2003), leads to similar observations as
those obtained with Fgf8 siRNA electroporation, including both
Bmp2 and Gata4 increased expression as well as supressed Fgf8
and Erk1/2 expression (Fig. 3B), at the level of the ipsilateral
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C. Lopez-Sanchez et al. / Developmental Biology 406 (2015) 63–7366endocardial tube. However, no signiﬁcant change is observed for
Nkx-2.5 expression.
Therefore, these data indicate that the topological application is
critical in Fgf8 signaling, determining the induction or/and in-
hibition of cardiac speciﬁc markers.
3.2. Bmp2 signaling positively regulates cardiac speciﬁc markers and
negatively regulates Fgf8 expression in ﬁrst cardiac ﬁeld
Given the observations obtained by Fgf8 analysis, we similarly
dissected the role of Bmp2 in cardiogenesis. Gain-of-function ex-
periments, by means of Bmp2 electroporation within the pro-
spective cardiogenic primitive streak cells at PS4 stage, resulted in
an increased expression of Nkx-2.5 and Gata4 at the level of pri-
mitive endocardial tubes (Fig. 4A). Curiously, both Fgf8 and Erk1/2
expressions were signiﬁcantly diminished by Bmp2. Further sup-
port on the up-regulation of Nkx-2.5 and Gata4 and down-reg-
ulation of Fgf8 and Erk1/2 expression by Bmp2 was obtained by
applying BMP2 soaked beads inside FCF (Fig. 4B). Importantly,
after the application of BMP2 –soaked beads- medially to FCF(Fig. 4C), Nkx-2.5, Gata4 and Fgf8 expression was induced, in line
with previous authors (Schultheiss et al., 1997; Andrée et al., 1998;
Schlange et al., 2000; Alsan and Schultheiss, 2002).
Remarkably, loss-of-function Bmp2 experiments (Fig. 4D),
through the application of noggin – soaked beads – inside FCF, led
to down regulation of Bmp2, Nkx-2.5 and Gata4 expression, while
no signiﬁcant changes were observed for Fgf8 and Erk1/2 expres-
sion. Therefore, these data further support the notion that topo-
logical application of both Fgf8 and Bmp2 is critical to induce or
inhibit cardiac speciﬁc markers.
3.3. miR-130 Regulates Fgf8–Bmp2 signaling during early cardiac
development
As we have mentioned above, Erk1/2 signaling decreases in
both types of experiments: those based on Fgf8 loss-of-function
(Fig. 3) and those involving Bmp2 gain-of-function (Fig. 4).
Through bioinformatic analyses by using Target-Scan on-line
software we identiﬁed miR-130 as a putative microRNA that tar-
gets Erk1/2 (MAPK) 3´UTR (Supplementary Fig. 2), thus suggesting
SU5402
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pression. Taking these data into account, by using ISH we have
performed an analysis of miR-130 expression from primitive
streak stages to primitive cardiac tube formation, and we have also
studied its involvement in the Fgf8/Bmp2 interaction.
Our results revealed that miR-130 expression starts at PS4 stage
in the primitive streak, followed by its expansion towards both
sides of the mesodermal and endodermal layers of the embryo at
PS8 stage. Later on, from PS13 onwards, miR-130 expression be-
comes restricted to precardiac mesoderm and underlyingendoderm (Fig. 5A). Interestingly Erk1/2 IMH analyses demon-
strated a complementary pattern (Fig. 5B), suggesting a plausible
regulatory link during early cardiogenesis. Additionally, we have
observed miR-130 expression in non precardiac regions (Supple-
mentary Fig. 3), including neural plate and notochord, as well as
emerging paraxial mesoderm and vessels, locations which are
overlapped with Erk1/2 signaling previously described (Lunn et al.,
2007).
In this context, miR-130 overexpression by means of electro-
poration led to inhibited Erk1/2 signal and Fgf8 expression, and
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pected, the electroporation of anti-miR-130 resulted in Erk1/2 and
Fgf8 increase, whereas Bmp2, Nkx-2.5 and Gata4 were suppressed
(Fig. 6B). Moreover, qRT-PCR analysis showed a marked increase of
Nkx-2.5 and Gata4 levels in endocardial tubes after miR-130
overexpression, as well as a substantial decrease after anti-miR-
130 electroporation (Fig. 6C). Thus, these ﬁndings corroborate the
results obtained by ISH.
Importantly, Bmp2 overexpression in precardiac primitive
streak cells increased miR-130 at the primitive endocardial tube
level (Fig. 7A), and likewise, the application of noggin-soaked
beads, speciﬁcally into the FCF, reduced miR-130 expression in the
ipsilateral endocardial tube (Fig. 7B).
Therefore, our ﬁndings indicate that miR-130 is an inter-
mediate effector on the Fgf8-Bmp2 signaling during early
cardiogenesis.4. Discussion
Transcription factors Nkx-2.5 (Schultheiss et al., 1995) and
Gata4 (Laverriere et al., 1994) are known to be the ﬁrst markers
identifying cardiac speciﬁcation at mesodermal level (ﬁrst cardiac
ﬁeld: FCF). It has been proposed that these earliest markers are
induced by Bmp2 and Fgf8, both expressed in the underlying en-
doderm (Schultheiss et al., 1997; Andrée et al., 1998; Schlange
et al., 2000; Alsan and Schultheiss, 2002; Brand, 2003). In this
work, a detailed analysis – by means of double ISH – has revealed
that Fgf8 is expressed medially in the endoderm underlying FCF,
while Bmp2 is expressed laterally, establishing two speciﬁc – yet
overlapping – areas of expression. Additionally, although Bmp2
expression was initially observed only in the underlying endoderm
(Schultheiss et al., 1997), it was further noted (Schlange et al.,
2000; Lopez-Sanchez and Garcia-Martinez, 2011) that Bmp2 is also
expressed in precardiac mesodermal cells during early cardiac
speciﬁcation. In this sense, it is important to mention that Fgf8 isexpressed only in the endoderm in chick development, whereas
mouse Fgf8 expression is observed at both endodermal and pre-
cardiac mesodermal levels (Crossley and Martin, 1995), as pre-
viously described in zebraﬁsh as well (Reifers et al., 2000). In this
study, we propose that this topographical distribution of gene
expression pattern in the embryonic layers plays an important role
as an inductive/repressive factor of the endoderm over the pre-
cardiac mesoderm.
4.1. Fgf8 suppresses while Bmp2 induces early cardiac markers
In our Fgf8 overexpression experiment – through electropora-
tion of primitive streak precardiac cells – we observed inhibition
of mesodermal cardiac marker Nkx-2.5 and Gata4. Additionally,
when we administrated FGF8 right inside FCF, it also resulted in
Nkx-2.5 and Gata4 inhibition. Since these results apparently dis-
agree with previous experiments, in which FGF8 was able to in-
duce Nkx-2.5 (Alsan and Schultheiss, 2002), we performed the
same experiments under the same conditions: we applied FGF8
just laterally to FCF, equally obtaining Nkx-2.5 ectopic induction.
All these results consequently demonstrate that topological loca-
tion of the inductive signals is crucial in this context. As an addi-
tional result, our loss-of-function experiments gave rise to Gata4
increase, both through Fgf8 siRNA electroporation – an inhibitor of
Fgf8 signaling – and SU5402 administration – a chemical FGFR
inhibitor, while Nkx-2.5 increases or maintains its expression, re-
spectively, this last result coinciding with previous experiments
(Alsan and Schultheiss, 2002). Thus, these data demonstrate the
disability to inhibit cardiac speciﬁc markers expression when
using a number of inhibitors of Fgf8 signaling during early cardiac
speciﬁcation. In addition, it has been reported that FGF8 admin-
istration at later stages of cardiogenesis represses Nkx-2.5 ex-
pression in the anterior heart ﬁeld, whereas SU5402 induces its
expression (Tirosh-Finkel et al., 2010). Moreover, studies in acer-
ebellar/fgf8 -a zebraﬁsh mutant with no expression of either Nkx-
2.5 or Gata4 (Reifers et al., 2000) reveal that the injection of Fgf8 is
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Fig. 6. Effect of miR-130 gain- and loss-of-function on primitive endocardial tube speciﬁcation. Whole-mount ISH for Bmp2, Nkx-2.5, Gata4 and Fgf8, and IMH for Erk1/2.
Embryos electroporated with pre-miR-130 (A) and anti-miR-130 (B) at the primitive streak precardiac cell level (left image). Visualization of CFDA in the immediate left or
right panels, respectively. (A): Note that at the primitive endocardial tube level Bmp2, Nkx-2.5 and Gata4 are markedly increased (arrows), whereas Fgf8 and Erk1/2 are
dramatically reduced (arrowheads). (B): Note that at the primitive endocardial tube level Bmp2, Nkx-2.5 and Gata4 are markedly suppressed (arrowheads), while Fgf8 and
Erk1/2 are increased (arrows). (C): RT-qPCR of RNA from dissected primitive endocardial tube (PET) areas (upper image) in embryos electroparated either with CFDA, pre-
miR-130 or anti-miR-130. Overexpression of miR-130 leads to increased Nkx-2.5 and Gata4 transcripts, whereas miR-130 inhibition leads to decreased transcripts. Standard
deviations are from three independent experiments. *Po0.01, **P o0.001 and ***P o0.0001.
C. Lopez-Sanchez et al. / Developmental Biology 406 (2015) 63–7370able to restore Gata4 but not Nkx-2.5. On the other hand, experi-
ments based on removal of the anterior endoderm (Alsan and
Schultheiss, 2002) result in loss of Nkx-2.5 expression (but not
Gata4), and this deﬁciency is rescued by applying FGF8 alone.
However, it is yet to be considered the possibility of an en-
dodermal regeneration inﬂuenced by FGF8, a known cellular
proliferative factor (Engelmann et al., 1993; Choy et al., 1996). In-
terestingly, noggin administration – a Bmp2 inhibitor – did not
modiﬁed Fgf8 expression, while Nkx-2.5 and Gata4 expression
were diminished. All the above data support that Fgf8 alone is
incapable to act as a direct cardiac inductive factor in FCF. There-
fore, this study brings new data with respect to the regulationprocess in cardiogenesis during chick development.
In reference to our Bmp2 overexpresion experiments, through
primitive streak precardiac cells electroporation, we observed an
increase in expression of Nkx-2.5 and Gata4. Furthermore, at the
ipsilateral primitive endocardial tube level, Nkx-2.5 and Gata4
expression areas were increased when administering BMP2, and
diminished when applying noggin beads, both inside FCF. It has
been shown that BMP2 administration, just medial to FCF, has the
ability to induce speciﬁc cardiac markers Nkx-2.5 and Gata4 ec-
topically (Schultheiss et al., 1997; Andrée et al., 1998; Schlange
et al., 2000; Alsan and Schultheiss, 2002), results that we also
obtained after reproducing the same experiment. The fact that
Bmp2 overexpression
Noggin
EGFP Control
miR-130EGFP
PS4
PS11
miR-130miR-130
Fig. 7. Effect of Bmp2 gain- and loss-of-function on primitive endocardial tube speciﬁcation. Whole-mount ISH for miR-130. (A): Embryo electroporated at the level of the
primitive streak precardiac cells (left image), either with the control construct or Bmp2 expressing construct. Note a marked increase of miR-130 (arrows) at the primitive
endocardial tube level. The white lines indicate the transverse section level. EGFP expression of experimental embryo is shown in the immediate left panel. (B): After noggin
soaked bead, applied just inside FCF (right drawing), miR-130 is diminished at the ipsilateral endocardial tube level (arrowhead).
C. Lopez-Sanchez et al. / Developmental Biology 406 (2015) 63–73 71Bmp2 is capable to induce Nkx-2.5 and Gata4 expression, both at
FCF and ectopic locations, supports that Bmp2 plays a key role in
cardiogenic inductive differentiation processes.
4.2. Fgf8–Bmp2 displays a negative feed-back loop in early
cardiogenesis
Another relevant result directly derived from our Bmp2 gain-of-
function experiments showed Fgf8 inhibition at primitive en-
docardial tube level. This was obtained through Bmp2 electro-
poration -at precardiac primitive streak level- as well as by ap-
plying BMP2 beads inside FCF. Nevertheless, when we applied
BMP2 beads medial to FCF, we observed ectopic Fgf8 expression,
result which is in agreement with previous studies (Alsan and
Schultheiss, 2002). Additionally, in this work we show the cap-
ability of Fgf8 to inhibit Bmp2 expression by using gain-of-function
experiments, supported by Fgf8 loss-of-function experiments,
which generate an increase in Bmp2 at primitive endocardial tube
level. This is the ﬁrst time that there is clear evidence of a negative
regulation of Bmp2 mediated by Fgf8 during early cardiogenesis,
aspect which has been pointed out at later stages of cardiac de-
velopment in a different experimental model in vitro (Kruithof
et al., 2006). The speciﬁc results we obtained – suppression of Fgf8
by Bmp2, suppression of Bmp2 by Fgf8, and separated topo-
graphical location of Bmp2 and Fgf8 endodermal expression – re-
veal the intervention of a negative Fgf8-Bmp2 feed-back me-
chanism responsible to deﬁne the ﬁrst cardiac ﬁeld. Thus, from the
underlying endoderm, Bmp2 signaling determines the ﬁrst step to
induce mesoderm cardiac speciﬁcation, whereas Fgf8 delimits
medially the ﬁrst cardiac ﬁeld, by means of an inhibitory effect. At
later stages of cardiac development, it has also been proposed that
Fgf8 regulates the position of the boundary between myocardium
and pericardial mesoderm in in vitro explant assay (Kruithof et al.,
2006). All the above data are supported by previous papers fo-
cused on different experimental models (Prall et al., 2007; Tirosh-
Finkel et al., 2010), describing that Fgf8 is mainly involved in cell
proliferation and Bmp2 is related to cell differentiation.
Our hypothesis is supported by the fact that Bmp2 is capable to
induce both Nkx-2.5 and Gata4 by overexpressing the signal just in
FCF, and also when BMP2 is administrated medially to FCF. This
probably indicates that Fgf8 is expressed in response to speciﬁc
levels of Bmp2 signals. Although Fgf8 is only able to induce Nkx-
2.5, and just laterally to FCF, we do not discard its possible role of
counteracting other endogenous factors which inhibit cardiac
differentiation laterally (Brand, 2003; Lopez-Sanchez and Garcia-
Martinez, 2011). Therefore, our model sets the bases for the initial
steps in cardiac speciﬁcation.4.3. miR130 Regulates negative Fgf8–Bmp2 feed-back
In order to gain a deeper insight into the mechanism involved
in negative Fgf8-Bmp2 feed-back loop, we have explored some
other different pathways responsible for cardiac speciﬁcation. It is
well known (Eblaghie et al., 2003; Echevarria et al., 2005; Lunn
et al., 2007) that Fgf signaling is mediated via tyrosine kinase re-
ceptors (FGFRs) by acting through a number of transduction
pathways, such as the highly conserved Ras-ERK mitogen-acti-
vated protein kinase (MAPK). In this work, there is evidence to
show the existence of a direct link between Fgf8 and Erk1/2 by
obtaining Erk1/2 inhibition at primitive endocardial tube level,
after both Fgf8 loss-of-function and Bmp2 gain-of-function ex-
periments. These interesting results show Erk1/2 as a regulatory
factor in the cardiac induction process. In this sense, previous
authors have proposed a similar active role of Bmp in the reg-
ulation of FGF/ERK pathway at later stages of cardiovascular de-
velopment, i.e., during cardiomyocyte differentiation of the ante-
rior heart ﬁeld (Tirosh-Finkel et al., 2010; Hutson et al., 2010), and
during modulation of myosin in vascular smooth muscle cells
(Zhang et al., 2014). Taking into account all the above data, we
have analyzed the possible inﬂuence of some additional factors in
order to establish a mechanism which justiﬁes a control pathway
of FGF/MAPK from Bmp2 during early cardiac speciﬁcation. Inter-
estingly, we identiﬁed miR-130 – through Target-Scan program
analysis – as a putative microRNA that targets ERK1/2 3´UTR. Mi-
croRNAs have shown to play a crucial role in several cardiac
(Chinchilla et al., 2011; Malizia and Wang, 2011; Chen and Wang,
2012) and angiogenic (Chen and Gorski 2008; Jakob et al., 2012)
developmental models. In particular, miR-130 has been predicted
to target a conserved region of FOG-2 3′UTR (Kim et al., 2009),
being FOG-2 a transcriptional co-factor critical for mouse cardiac
development, modulator of Gata4 (Svensson et al., 1999).
Our detailed analysis of miR-130 expression pattern during
early gastrula stages revealed its distribution at the primitive
streak level, including the precardiac cells, followed by its ex-
pression in the precardiac mesoderm as well as in the underlying
endoderm. The fact that this expression pattern is coincident with
Erk1/2 signal at these developing stages evidence a close re-
lationship between miR-130 and Erk1/2 during cardiogenesis.
After our miR-130 gain-of-function experiments, we observed
that Erk1/2 signal diminishes, followed by a decrease of Fgf8. In-
terestingly, Bmp2 expression increased, and consequently, cardiac
markers Nkx-2.5 and Gata4 increased as well. These data are
supported by the results we obtained from miR-130 loss-of-func-
tion experiments, where we observed that Erk1/2 and Fgf8 in-
crease, whereas Bmp2 diminishes, and consequently, Nkx-2.5 and
Gata4 decrease as well. Additionally, our Bmp2 overexpression
Bmp2 Fgf8
Erk1/2
miR-130
Gata4 Nkx-2.5
Anti-miR-130
Noggin Fgf8 siRNA
Early Cardiac Specification
SU5402FGFR1
Fig. 8. Proposed model for early cardiac speciﬁcation. Our model indicates that the
earliest cardiac markers -Nkx-2.5 and Gata4- are induced by Bmp2. Fgf8 represses
Bmp2. Moreover, Bmp2 induces miR-130, which represses Erk1/2. Since Fgf8 is
controlled via Erk1/2, our model presents Bmp2 as a modulator of Fgf8 expression
through miR-130. Thus, miR-130 acts as necessary linkage in the control of Fgf8
signaling, mediated by Bmp2, establishing a negative feed-back loop responsible to
achieve the initial cardiac speciﬁcation.
C. Lopez-Sanchez et al. / Developmental Biology 406 (2015) 63–7372experiments resulted in an increase of miR-130 expression. In
agreement with that, after noggin administration, we obtained an
inhibition of miR-130 expression. Our data support that miR-130,
upstream-regulated by Bmp2, controls Erk1/2 signaling, either
repressing its translation and/or transcript stability. In our illus-
trative Diagram (Fig. 8A) we draw the various links proposed in
early cardiac speciﬁcation. We could hypothesize a pathway in
which Bmp2 signal controls Fgf8 via Erk1/2, mediated by miR-130,
which is acting as a regulator in cardiac speciﬁcation. Finally, since
Fgf8 constitutes an essential factor involved in MAPK/ERK in-
tracellular signaling (Echevarria et al., 2005), it is reasonable to
consider additional factors involved in this pathway, such as FGF
receptors, which play a signiﬁcant role as early steps in the Fgf8/
ERK signaling pathway (Hadari et al., 1998; Dell'Era et al., 2003).
Although a relevant effect of those receptors has not yet been
demonstrated during cardiac induction, some authors have iden-
tiﬁed FGFR1 in the endoderm underlying the precardiac meso-
derm (Sugi et al., 1995; Lunn et al., 2007). However, its functional
role has been reported in growth and proliferation rather than in
differentiation (Zhu et al., 1999). In this sense, it has been pre-
viously reported that cardiomyocyte proliferation decreases after
miR-133 overexpression (Liu et al., 2008). In line with this, we
have observed that miR-133 is expressed in all the precardiac areas
during early cardiogenesis (Lopez-Sanchez et al., submitted), ex-
pression pattern which is comparable to distribution FGFR1 (Sugi
et al., 1995; Lunn et al., 2007). In order to gain a deeper insight into
the linkage between miR-133 and FGFR1, we developed additionalexperimental designs, showing a reciprocal repression between
Fgf8 and miR-133. We propose that this cooperation plays a crucial
role in Fgf8/ERK pathway cascade, probably mediated by FGFR1,
through Bmp2 signaling.
In conclusion, our study reveals for the ﬁrst time a key role of
miR-130 in molecular regulation during early cardiogenesis. This
model proposes a regulation of Erk1/2 (MAPK) through miR-130.
Therefore, this microRNA functions as a necessary linkage in the
control of Fgf8 signaling mediated by Bmp2. This mechanism es-
tablishes a negative feed-back loop responsible for Nkx-2.5 and
Gata4 induction to achieve the early cardiac speciﬁcation (Fig. 8B).Acknowledgments
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